IVERIC bio Inc
Change company Symbol lookup
Select an option...
ISEE IVERIC bio Inc
HUN Huntsman Corp
IART Integra Lifesciences Holdings Corp
R Ryder System Inc
AAPL Apple Inc
IIM Invesco Value Municipal Income Trust
QQQ Invesco QQQ Trust
VZ Verizon Communications Inc
CHTR Charter Communications Inc
SPB Spectrum Brands Holdings Inc
Go

Health Care : Biotechnology | Small Cap Growth
Company profile

IVERIC bio, Inc. is a biopharmaceutical company. The Company is focused on the discovery and development ofl treatments for retinal diseases with unmet medical needs. Its lead asset clinical stage product candidate Zimura, a complement C5 inhibitor. Zimura is targeting diseases include: Geographic Atrophy (GA), intermediate (age-related macular degeneration) AMD, and autosomal recessive Stargardt disease (STGD1). It is also developing preclinical product candidate IC-500, a High temperature requirement A serine peptidase 1 protein (HtrA1) inhibitor for GA and potentially other age-related retinal diseases. Its portfolio also includes two preclinical stage gene therapy product candidates, which include IC-100 and IC-200 and several ongoing gene therapy research programs. The Company is developing IC-100 for rhodopsin-mediated autosomal dominant retinitis pigmentosa (RHO-adRP) and IC-200 for bestrophin-1 (BEST1) related IRDs.

Price
Delayed
$13.49
Day's Change
0.005 (0.04%)
Bid
--
Ask
--
B/A Size
--
Day's High
13.52
Day's Low
13.16
Volume
(Light)

Today's volume of 604,298 shares is on pace to be much lighter than ISEE's 10-day average volume of 2,109,201 shares.

604,298
  • Prev Close
    13.48
  • Today's Open
    13.27
  • Day's Range
    13.16-13.52
  • Avg Vol (10-day)
    2.1M
  • Last (time)
    3:13p ET 08/15/22
  • Last (size)
    200
  • 52-Wk Range
    8.37 - 19.35
    LowHigh
  • (09/09/21 - 04/05/22)
    61.11%
  • 82.8%
  • Market Cap
    1.6B
  • Shares Outstanding
    118.1M
  • -1.22
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.5
  • 107.30
  • (% of float 07/29/22)
    5.85

Latest News

August 10, 2022
8:00 am ET
BusinessWire
August 03, 2022
8:00 am ET
BusinessWire
August 02, 2022
8:38 am ET
MarketWatch
8:00 am ET
BusinessWire
July 26, 2022
6:32 am ET
BusinessWire
6:30 am ET
BusinessWire
July 21, 2022
4:18 pm ET
BusinessWire
July 16, 2022
11:15 am ET
BusinessWire
July 07, 2022
12:10 pm ET
MarketWatch
July 06, 2022
2:00 am ET
PR Newswire
July 05, 2022
7:30 am ET
BusinessWire
July 01, 2022
4:52 pm ET
BusinessWire
June 10, 2022
7:00 am ET
BusinessWire
June 02, 2022
8:00 am ET
BusinessWire
May 12, 2022
7:26 am ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.